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Missense mutations of mismatch repair (MMR) genes
– MLH1, MSH2, MSH6 and PMS2 – may (but do not
necessarily) play a role in the etiology of the Lynch
syndrome (LS) which is one of the hereditary cancer
susceptibility syndromes. Pathogenic mutations in one
of those genes result in a higher risk of developing
cancer in colon, endometrium, small intestine, ovary,
urinary tract, stomach or breast. One in ten patients
with LS have a germline mutation in MSH6, and 40%
of all mutations in that gene are single amino acid
substitutions.
One of the elements taking part in the MMR process
is the MSH6 protein which, along with MSH2, is a
component of a protein dimer – MutSa. MMR func-
tion is critical in maintaining cellular DNA integrity.
Loss of that function results in increased number of
uncorrected mutations which may lead to malignant
tissue transformation. This is why it is crucial to deter-
mine whether the detected change is located in a DNA
sequence coding the MMR protein and if it impairs the
repair function. Alas, the consequences of single amino
acid substitution are often harder to evaluate than out-
comes of deletions, insertions or nonsense mutations.
Moreover, performing a functional and molecular ana-
lysis for each detected alteration would be too expen-
sive and unrealistic. This is where the use of prediction
software would be of assistance.
The intent of this thesis was to determine the patho-
genic significance of a set of missense mutations using
selected in silico analysis tools and to evaluate their utility
in everyday use.
Twenty-one MSH6 missense mutations were analyzed,
three of them already classified as non-pathogenic
polymorphisms, and two had confirmed pathogenic status.
They were used accordingly as negative and positive
controls.
Three online programs were used for the analysis of
those mutations, which allowed to evaluate each substi-
tution from a different angle. SIFT utilizes alignment of
homologous sequences from variety of organisms to
determine the conservation of the substitution site and
thereby estimates the potential pathogenicity of a
mutation. PolyPhen-2 prediction is based on the
sequence, protein structure and position of each muta-
tion. The last of the used programs was ESEfinder
which tested the impact of a mutation on the presence
of ESEs (Exonic Splicing Enhancers) in the examined
sequence.
After performing the in silico analysis and confronting
the results with data available in literature and the Internet
databases, it was established that next to one of the
changes confirmed as non-pathogenic polymorphisms,
there are probably eight further non-pathogenic ones. Like-
wise, beside the two confirmed pathogenic alterations, in
the analyzed set there were probably five additional patho-
genic mutations. The last group is formed by substitutions
that remain uncertain because of their ambiguous results.
Following the analysis of the results and available data,
a conclusion was reached that the sole use of in silico
prediction is not sufficient for a complete classification
of the mutations, but they may be helpful for decision
making in choosing or prioritizing the variants worth
further analysis.
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